Auditor TAAD resigns; four directors/officers exit; Dr. Lai appointed CEO/CFO/Chair

VITASPRING BIOMEDICAL CO. LTD.

TAAD LLP resigned as independent auditor effective Aug 5, 2025; no disagreements or reportable events.
Effective Aug 7, 2025, Lin Jer-Li, Chen YenXun, Chu Pao-Chi, and Kao Cheng-Hsiang resigned from all positions.
Dr. Ssu-Chuan Lai appointed Chairperson, CEO, and CFO effective Aug 7, 2025.
Dr. Lai previously Vice General Manager at Biospring Medical, with cell manufacturing and regulatory expertise.
Resignations were not due to any disagreements with the company's operations, policies, or practices.

item 4.01item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.